Seroprevalence of syphilis, hepatitis B and C, and human immunodeficiency virus infections among women

Saudi Medical Journal

Volumn 25, Issue 12, 2004, Pages 2037-2038

  Demirel, Yeltekin ^a   Duran, Bulent ^b   Toktamis, Aydin ^a   Erden, Omur ^b   Cetin, Meral ^b  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INTERFERON; RIBAVIRIN;

ADULT; AGED; ARTICLE; BLOOD DONOR; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS B; HEPATITIS C; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; INFECTION RISK; LIFESTYLE; MAJOR CLINICAL STUDY; MASS SCREENING; POPULATION RISK; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SAFETY; SEXUAL TRANSMISSION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE ABUSE; SYPHILIS; TURKEY (REPUBLIC); VALIDATION PROCESS; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

BLOOD DONORS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B; HEPATITIS C; HIV SEROPREVALENCE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; STATISTICS; SYPHILIS; SYPHILIS SERODIAGNOSIS; TURKEY;

EID: 13844281343     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Nas T, Taner MZ, Yildiz A. Seroprevalence of syphilis, human immunodeficiency virus type-1, and hepatitis B virus infections among pregnant women in Turkey. Int J Gynaecol Obstet 1999; 66: 171-172.
2. Butsashvili M, Tsertsvadze T, McNutt LA, Kamkamidze G, Gvetadze R, Badridze N. Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. Eur J Epidemiol 2001; 17: 693-695.
3. Stroffolini T, Bianco E, Szklo A, Bernacchia R, Bove C, Colucci M, et al. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine 2003; 21: 1246-1249.
4. Euler GL, Wooten KG, Baughman AL, Williams WW. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics 2003; 111 (5 Part 2): 1192-1197.
5. Hadzic N. Hepatitis C in pregnancy. Arch Dis Child Fetal Neonatal Ed 2001; 84: F201-F2014.
6. Burns DN, Minkoff H. Hepatitis C: screening in pregnancy. Obstet Gynecol 1999; 94: 1044-1048.
7. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173-1180.
8. Schrag SJ, Arnold KE, Mohle-Boetani JC, Lynfield R, Zell ER, Stefonek K, et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 2003; 102: 753-760.